Clinical Trials Browser

Phase 3 × Dexmedetomidine × 90 days × Clear all

NCT03063073 2026-02-12

pec's

Phase 3 Completed

Breast Cancer Female

NCT05439005 2026-01-30

OFOBA

Phase 3 Recruiting

Breast Neoplasms